Arcus Capital Partners’s 2ndVote Life Neutral Plus ETF LYFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,671
Closed -$48.5K 378
2022
Q4
$48.5K Buy
+1,671
New +$49.8K 0.02% 181

Other funds holding LYFE

Arcus Capital Partners's LYFE Position: Q1 2023 in Review

Arcus Capital Partners sold out of 2ndVote Life Neutral Plus ETF (LYFE) in Q1 2023, closing a stake of 1,671 shares — an estimated $48.5K sold.

Arcus Capital Partners first reported a position in LYFE in Q4 2022 and held it in 1 quarter. The position peaked at $48.5K in Q4 2022. 11 funds tracked by Wall St. Rank hold LYFE as of Q1 2023.

  • Arcus Capital Partners reported no remaining 2ndVote Life Neutral Plus ETF position as of Q1 2023 after selling out during the quarter.
  • Arcus Capital Partners sold 1,671 2ndVote Life Neutral Plus ETF shares in Q1 2023, an estimated $48.5K.
  • Arcus Capital Partners first reported a position in 2ndVote Life Neutral Plus ETF in Q4 2022 and held it in 1 quarter.
  • Arcus Capital Partners's 2ndVote Life Neutral Plus ETF position peaked at $48.5K in Q4 2022.
  • 11 funds tracked by Wall St. Rank held 2ndVote Life Neutral Plus ETF as of Q1 2023.

Based on Arcus Capital Partners's 13F filing for Q1 2023, filed 9 May 2023.